BioCentury
ARTICLE | Finance

3rd Quarter Stock Preview: Making the Milestone

July 6, 2009 7:00 AM UTC

Buysiders expect the summer months, as always, to be a little light on events. While some are hoping for a few dramatic upside moves among some neglected small caps, most buysiders were hesitant to disclose their picks as they remain on the sidelines or are in the midst of accumulating shares in very illiquid stocks.

"Usually 4Q is much more important than 3Q, as most healthcare conferences take place at that time and it is the presentation of results that moves stock prices, especially in the small and mid-cap area," Julius Baer's Nathalie Flury told BioCentury (see "2H09 Milestones," A9). ...